About The Cover
The cover for issue 43 of Oncotarget features Figure 6, "(A) Following the experimental protocol of Franzetti et al. [11] A673-shA1c cells −/+ Dox (EWS/Fli1high/EWS/Fli1low) were injected into the tail vein, and metastases were allowed to form in the absence of further Dox treatment (to allow recovery of cell growth in EWS/Fli1low cells)," by McCann, et al.
Table of Contents
Research Papers
Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis
| Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis |
|
https://doi.org/10.18632/oncotarget.27774 Takehiro Shiraishi, Eiji Shinto, Masato Yamadera, Ken Nagata, Hitoshi Tsuda, Satsuki Mochizuki, Yoshiki Kajiwara, Koichi Okamoto, Takahiro Einama, Yoji Kishi, and Hideki Ueno |
| 3807-3817 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma
| KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.27737 Tyler S. McCann, Janet K. Parrish, Joseph Hsieh, Marybeth Sechler, Lays M. Sobral, Chelsea Self, Kenneth L. Jones, Andrew Goodspeed, James C. Costello, and Paul Jedlicka |
| 3818-3831 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Regulation of breast cancer oncogenesis by the cell of origin’s differentiation state
| Regulation of breast cancer oncogenesis by the cell of origin’s differentiation state |
|
https://doi.org/10.18632/oncotarget.27783 Sarah C. Petrova, Ihsaan Ahmad, Christine Nguyen, Stuart D. Ferrell Jr, Sabrina R. Wilhelm, Yin Ye, and Sanford H. Barsky |
| 3832-3848 |
| Abstract | PDF | Full Text | How to cite |
Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer
| Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer |
|
https://doi.org/10.18632/oncotarget.27766 Thomas M. Cardillo, Diane L. Rossi, Maria B. Zalath, Donglin Liu, Roberto Arrojo, Robert M. Sharkey, Chien-Hsing Chang, and David M. Goldenberg |
| 3849-3862 |
| Abstract | PDF | Full Text | How to cite | Press Release |
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis
| Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis |
|
https://doi.org/10.18632/oncotarget.27743 Myoung Sook Kim, Ramkishore Gernapudi, Yessenia Cedeño Cedeño, Brian M. Polster, Ramon Martinez, Paul Shapiro, Santosh Kesari, Elmar Nurmemmedov, and Antonino Passaniti |
| 3863-3885 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Heterogeneity of CEACAM5 in breast cancer
| Heterogeneity of CEACAM5 in breast cancer |
|
https://doi.org/10.18632/oncotarget.27778 Marc B. Bechmann, Andreas V. Brydholm, Victoria L. Codony, Jiyoung Kim, and René Villadsen |
| 3886-3899 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Copyright © 2025 Rapamycin Press LLC dba Impact Journalss
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC